The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Ophthalmic Therapeutics & Drug-Global Market Insights and Sales Trends 2025
Synopsis
The global Ophthalmic Therapeutics & Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ophthalmic Therapeutics & Drug in various end use industries. The expanding demands from the Dry Eye, Allergies, Glaucoma and Infection, are propelling Ophthalmic Therapeutics & Drug market. Anti-allergy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anti-VEGF Agents segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ophthalmic Therapeutics & Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ophthalmic Therapeutics & Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ophthalmic Therapeutics & Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ophthalmic Therapeutics & Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ophthalmic Therapeutics & Drug covered in this report include Alcon, Johnson and Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Novartis AG, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals Inc., Allergan, Pfizer Inc. and Valeant, etc.
The global Ophthalmic Therapeutics & Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alcon
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Novartis AG
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals Inc.
Allergan
Pfizer Inc.
Valeant
Bayer AG
Santen Pharmaceuticals Co. Ltd
Genentech, Inc.
Global Ophthalmic Therapeutics & Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ophthalmic Therapeutics & Drug market, Segment by Type:
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others
Global Ophthalmic Therapeutics & Drug market, by Application
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Ophthalmic Therapeutics & Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Ophthalmic Therapeutics & Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Ophthalmic Therapeutics & Drug in various end use industries. The expanding demands from the Dry Eye, Allergies, Glaucoma and Infection, are propelling Ophthalmic Therapeutics & Drug market. Anti-allergy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anti-VEGF Agents segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Ophthalmic Therapeutics & Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Ophthalmic Therapeutics & Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Ophthalmic Therapeutics & Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Ophthalmic Therapeutics & Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Ophthalmic Therapeutics & Drug covered in this report include Alcon, Johnson and Johnson Vision Care, Inc., Bausch & Lomb Incorporated, Novartis AG, Merck Sharp & Dohme Corp., Regeneron Pharmaceuticals Inc., Allergan, Pfizer Inc. and Valeant, etc.
The global Ophthalmic Therapeutics & Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Alcon
Johnson and Johnson Vision Care, Inc.
Bausch & Lomb Incorporated
Novartis AG
Merck Sharp & Dohme Corp.
Regeneron Pharmaceuticals Inc.
Allergan
Pfizer Inc.
Valeant
Bayer AG
Santen Pharmaceuticals Co. Ltd
Genentech, Inc.
Global Ophthalmic Therapeutics & Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Ophthalmic Therapeutics & Drug market, Segment by Type:
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Others
Global Ophthalmic Therapeutics & Drug market, by Application
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Ophthalmic Therapeutics & Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Ophthalmic Therapeutics & Drug
1.1 Ophthalmic Therapeutics & Drug Market Overview
1.1.1 Ophthalmic Therapeutics & Drug Product Scope
1.1.2 Ophthalmic Therapeutics & Drug Market Status and Outlook
1.2 Global Ophthalmic Therapeutics & Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Ophthalmic Therapeutics & Drug Market Size by Region (2018-2029)
1.4 Global Ophthalmic Therapeutics & Drug Historic Market Size by Region (2018-2023)
1.5 Global Ophthalmic Therapeutics & Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Ophthalmic Therapeutics & Drug Market Size (2018-2029)
1.6.1 North America Ophthalmic Therapeutics & Drug Market Size (2018-2029)
1.6.2 Europe Ophthalmic Therapeutics & Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Ophthalmic Therapeutics & Drug Market Size (2018-2029)
1.6.4 Latin America Ophthalmic Therapeutics & Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Ophthalmic Therapeutics & Drug Market Size (2018-2029)
2 Ophthalmic Therapeutics & Drug Market by Type
2.1 Introduction
2.1.1 Anti-allergy
2.1.2 Anti-VEGF Agents
2.1.3 Anti-inflammatory
2.1.4 Anti-glaucoma
2.1.5 Others
2.2 Global Ophthalmic Therapeutics & Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Ophthalmic Therapeutics & Drug Historic Market Size by Type (2018-2023)
2.2.2 Global Ophthalmic Therapeutics & Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Ophthalmic Therapeutics & Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Ophthalmic Therapeutics & Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Ophthalmic Therapeutics & Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Ophthalmic Therapeutics & Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Ophthalmic Therapeutics & Drug Revenue Breakdown by Type (2018-2029)
3 Ophthalmic Therapeutics & Drug Market Overview by Application
3.1 Introduction
3.1.1 Dry Eye
3.1.2 Allergies
3.1.3 Glaucoma
3.1.4 Infection
3.1.5 Retinal Disorders
3.1.6 Uveitis
3.1.7 Others
3.2 Global Ophthalmic Therapeutics & Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Ophthalmic Therapeutics & Drug Historic Market Size by Application (2018-2023)
3.2.2 Global Ophthalmic Therapeutics & Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Ophthalmic Therapeutics & Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Ophthalmic Therapeutics & Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Ophthalmic Therapeutics & Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Ophthalmic Therapeutics & Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Ophthalmic Therapeutics & Drug Revenue Breakdown by Application (2018-2029)
4 Ophthalmic Therapeutics & Drug Competition Analysis by Players
4.1 Global Ophthalmic Therapeutics & Drug Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Ophthalmic Therapeutics & Drug as of 2022)
4.3 Date of Key Players Enter into Ophthalmic Therapeutics & Drug Market
4.4 Global Top Players Ophthalmic Therapeutics & Drug Headquarters and Area Served
4.5 Key Players Ophthalmic Therapeutics & Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Ophthalmic Therapeutics & Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Alcon
5.1.1 Alcon Profile
5.1.2 Alcon Main Business
5.1.3 Alcon Ophthalmic Therapeutics & Drug Products, Services and Solutions
5.1.4 Alcon Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2018-2023)
5.1.5 Alcon Recent Developments
5.2 Johnson and Johnson Vision Care, Inc.
5.2.1 Johnson and Johnson Vision Care, Inc. Profile
5.2.2 Johnson and Johnson Vision Care, Inc. Main Business
5.2.3 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics & Drug Products, Services and Solutions
5.2.4 Johnson and Johnson Vision Care, Inc. Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson and Johnson Vision Care, Inc. Recent Developments
5.3 Bausch & Lomb Incorporated
5.3.1 Bausch & Lomb Incorporated Profile
5.3.2 Bausch & Lomb Incorporated Main Business
5.3.3 Bausch & Lomb Incorporated Ophthalmic Therapeutics & Drug Products, Services and Solutions
5.3.4 Bausch & Lomb Incorporated Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis AG Recent Developments
5.4 Novartis AG
5.4.1 Novartis AG Profile
5.4.2 Novartis AG Main Business
5.4.3 Novartis AG Ophthalmic Therapeutics & Drug Products, Services and Solutions
5.4.4 Novartis AG Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis AG Recent Developments
5.5 Merck Sharp & Dohme Corp.
5.5.1 Merck Sharp & Dohme Corp. Profile
5.5.2 Merck Sharp & Dohme Corp. Main Business
5.5.3 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics & Drug Products, Services and Solutions
5.5.4 Merck Sharp & Dohme Corp. Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2018-2023)
5.5.5 Merck Sharp & Dohme Corp. Recent Developments
5.6 Regeneron Pharmaceuticals Inc.
5.6.1 Regeneron Pharmaceuticals Inc. Profile
5.6.2 Regeneron Pharmaceuticals Inc. Main Business
5.6.3 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics & Drug Products, Services and Solutions
5.6.4 Regeneron Pharmaceuticals Inc. Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2018-2023)
5.6.5 Regeneron Pharmaceuticals Inc. Recent Developments
5.7 Allergan
5.7.1 Allergan Profile
5.7.2 Allergan Main Business
5.7.3 Allergan Ophthalmic Therapeutics & Drug Products, Services and Solutions
5.7.4 Allergan Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2018-2023)
5.7.5 Allergan Recent Developments
5.8 Pfizer Inc.
5.8.1 Pfizer Inc. Profile
5.8.2 Pfizer Inc. Main Business
5.8.3 Pfizer Inc. Ophthalmic Therapeutics & Drug Products, Services and Solutions
5.8.4 Pfizer Inc. Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2018-2023)
5.8.5 Pfizer Inc. Recent Developments
5.9 Valeant
5.9.1 Valeant Profile
5.9.2 Valeant Main Business
5.9.3 Valeant Ophthalmic Therapeutics & Drug Products, Services and Solutions
5.9.4 Valeant Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2018-2023)
5.9.5 Valeant Recent Developments
5.10 Bayer AG
5.10.1 Bayer AG Profile
5.10.2 Bayer AG Main Business
5.10.3 Bayer AG Ophthalmic Therapeutics & Drug Products, Services and Solutions
5.10.4 Bayer AG Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2018-2023)
5.10.5 Bayer AG Recent Developments
5.11 Santen Pharmaceuticals Co. Ltd
5.11.1 Santen Pharmaceuticals Co. Ltd Profile
5.11.2 Santen Pharmaceuticals Co. Ltd Main Business
5.11.3 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics & Drug Products, Services and Solutions
5.11.4 Santen Pharmaceuticals Co. Ltd Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2018-2023)
5.11.5 Santen Pharmaceuticals Co. Ltd Recent Developments
5.12 Genentech, Inc.
5.12.1 Genentech, Inc. Profile
5.12.2 Genentech, Inc. Main Business
5.12.3 Genentech, Inc. Ophthalmic Therapeutics & Drug Products, Services and Solutions
5.12.4 Genentech, Inc. Ophthalmic Therapeutics & Drug Revenue (US$ Million) & (2018-2023)
5.12.5 Genentech, Inc. Recent Developments
6 North America
6.1 North America Ophthalmic Therapeutics & Drug Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Ophthalmic Therapeutics & Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Ophthalmic Therapeutics & Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Ophthalmic Therapeutics & Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Ophthalmic Therapeutics & Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Ophthalmic Therapeutics & Drug Market Dynamics
11.1 Ophthalmic Therapeutics & Drug Industry Trends
11.2 Ophthalmic Therapeutics & Drug Market Drivers
11.3 Ophthalmic Therapeutics & Drug Market Challenges
11.4 Ophthalmic Therapeutics & Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
